Current and historical daily PE Ratio for SHC (
Sotera Health Co
) from 2020 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sotera Health stock (SHC) PE ratio as of May 17 2024 is 59.42.
More Details
Sotera Health Co (SHC) PE Ratio (TTM) Chart
Sotera Health Co (SHC) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 877
- 1
- 2
- 3
- 4
- 5
- 6
- 10
| Sotera Health PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-17 | 59.4 | 2024-03-14 | 78.8 |
| 2024-05-16 | 60.0 | 2024-03-13 | 77.4 |
| 2024-05-15 | 60.0 | 2024-03-12 | 76.5 |
| 2024-05-14 | 60.0 | 2024-03-11 | 77.8 |
| 2024-05-13 | 59.9 | 2024-03-08 | 76.8 |
| 2024-05-10 | 58.1 | 2024-03-07 | 77.7 |
| 2024-05-09 | 59.6 | 2024-03-06 | 79.1 |
| 2024-05-08 | 59.0 | 2024-03-05 | 77.8 |
| 2024-05-07 | 60.4 | 2024-03-04 | 81.1 |
| 2024-05-06 | 59.4 | 2024-03-01 | 80.9 |
| 2024-05-03 | 58.0 | 2024-02-29 | 83.4 |
| 2024-05-02 | 57.4 | 2024-02-28 | 83.1 |
| 2024-05-01 | 59.3 | 2024-02-27 | 96.3 |
| 2024-04-30 | 59.0 | 2024-02-26 | 94.8 |
| 2024-04-29 | 59.9 | 2024-02-23 | 93.4 |
| 2024-04-26 | 60.0 | 2024-02-22 | 92.2 |
| 2024-04-25 | 59.6 | 2024-02-21 | 91.1 |
| 2024-04-24 | 59.3 | 2024-02-20 | 90.3 |
| 2024-04-23 | 59.9 | 2024-02-16 | 92.3 |
| 2024-04-22 | 58.4 | 2024-02-15 | 93.3 |
| 2024-04-19 | 57.6 | 2024-02-14 | 92.6 |
| 2024-04-18 | 57.4 | 2024-02-13 | 88.3 |
| 2024-04-17 | 56.6 | 2024-02-12 | 89.6 |
| 2024-04-16 | 57.3 | 2024-02-09 | 90.4 |
| 2024-04-15 | 58.0 | 2024-02-08 | 88.8 |
| 2024-04-12 | 59.4 | 2024-02-07 | 84.6 |
| 2024-04-11 | 60.1 | 2024-02-06 | 86.8 |
| 2024-04-10 | 60.1 | 2024-02-05 | 84.2 |
| 2024-04-09 | 61.2 | 2024-02-02 | 83.6 |
| 2024-04-08 | 60.0 | 2024-02-01 | 85.1 |
| 2024-04-05 | 59.7 | 2024-01-31 | 81.8 |
| 2024-04-04 | 60.0 | 2024-01-30 | 81.2 |
| 2024-04-03 | 60.7 | 2024-01-29 | 83.4 |
| 2024-04-02 | 59.9 | 2024-01-26 | 83.2 |
| 2024-04-01 | 61.6 | 2024-01-25 | 82.9 |
| 2024-03-28 | 63.2 | 2024-01-24 | 81.3 |
| 2024-03-27 | 65.9 | 2024-01-23 | 83.4 |
| 2024-03-26 | 64.1 | 2024-01-22 | 84.6 |
| 2024-03-25 | 65.3 | 2024-01-19 | 83.2 |
| 2024-03-22 | 62.8 | 2024-01-18 | 81.7 |
| 2024-03-21 | 64.1 | 2024-01-17 | 81.6 |
| 2024-03-20 | 65.4 | 2024-01-16 | 84.6 |
| 2024-03-19 | 72.8 | 2024-01-12 | 85.2 |
| 2024-03-18 | 79.6 | 2024-01-11 | 84.8 |
| 2024-03-15 | 80.7 | 2024-01-10 | 86.4 |
Sotera Health Co (SHC) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sotera Health Co
NAICS : 541380
SIC : 8071
ISIN : US83601L1026
Share Class Description:
SHC: Ordinary SharesDescription
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers